Litcius/Paper detail

Norboldine improves cognitive impairment and pathological features in Alzheimer's disease by activating AMPK/GSK3β/Nrf2 signaling pathway

Yuqing Zeng, Xiong Li, Hao Tang, Linjie Chen, Qin Yu, Liwei Li, Fan Chen, Luyao Li, Yanyan Zheng, Jinfeng Sun, Lingyu She, Wei Wang, Guang Liang, Xia Zhao

2024Journal of Ethnopharmacology18 citationsDOI

Topics & Concepts

AMPKPathologicalDiseaseSignal transductionDementiaMedicineAlzheimer's diseaseCognitive impairmentNeurosciencePathogenesisBiologyPhosphorylationInternal medicineCell biologyProtein kinase AAlzheimer's disease research and treatmentsCholinesterase and Neurodegenerative DiseasesGenomics, phytochemicals, and oxidative stress
Norboldine improves cognitive impairment and pathological features in Alzheimer's disease by activating AMPK/GSK3β/Nrf2 signaling pathway | Litcius